Myriad Genetics buy Wolfe Research
Start price
13.12.23
/
50%
€18.00
Target price
13.12.24
€25.92
Performance (%)
-23.89%
End price
14.12.24
€13.70
Summary
This prediction ended on 14.12.24 with a price of €13.70. The price of Myriad Genetics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.89%. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -10.294% | -10.294% | -47.714% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Wolfe_Research for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten